Advertisement
Screener

AbbVie Inc. (ABBV) Earnings Per Share (Basic)

2.8 / 5 stars · 68/120 Roast Me

AbbVie Inc. Earnings Per Share (Basic)

AbbVie Inc. (ABBV) reported Earnings Per Share (Basic) of $2.04 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasic · last filed 2026-08-03

  • AbbVie Inc. earnings per share, basic for the quarter ending 2026-06-30 was $2.04, a 292.31% increase year-over-year.
  • AbbVie Inc. earnings per share, basic for the quarter ending 2026-03-31 was $0.39, a 45.83% decline year-over-year.
  • AbbVie Inc. earnings per share, basic for the quarter ending 2025-12-31 was $1.02.
  • AbbVie Inc. earnings per share, basic for the quarter ending 2025-09-30 was $0.10, a 88.64% decline year-over-year.
  • AbbVie Inc. earnings per share, basic for fiscal 2025 was $2.37, a 1.25% decline from fiscal 2024.
  • AbbVie Inc. earnings per share, basic for fiscal 2024 was $2.40, a 12.09% decline from fiscal 2023.
  • AbbVie Inc. earnings per share, basic for fiscal 2023 was $2.73, a 58.95% decline from fiscal 2022.
  • AbbVie Inc. earnings per share, basic for fiscal 2022 was $6.65, a 2.62% increase from fiscal 2021.
Period endEarnings Per Share, Basic 3 monthEarnings Per Share, Basic 6 monthEarnings Per Share, Basic 9 monthEarnings Per Share, Basic 12 month
2026-06-30$2.04
10-Q · filed 2026-08-03
$2.42
10-Q · filed 2026-08-03
$3.44
derived: net income ÷ weighted average shares · filed 2026-08-03
$3.54
derived: net income ÷ weighted average shares · filed 2026-08-03
2026-03-31$0.39
10-Q · filed 2026-05-08
$1.41
derived: net income ÷ weighted average shares · filed 2026-05-08
$1.51
derived: net income ÷ weighted average shares · filed 2026-05-08
$2.03
derived: net income ÷ weighted average shares · filed 2026-08-03
2025-12-31$1.02
10-K · filed 2026-02-20
$1.12
derived: net income ÷ weighted average shares · filed 2026-02-20
$1.65
derived: net income ÷ weighted average shares · filed 2026-08-03
$2.37
10-K · filed 2026-02-20
2025-09-30$0.10
10-Q · filed 2025-11-04
$0.62
derived: net income ÷ weighted average shares · filed 2026-08-03
$1.35
10-Q · filed 2025-11-04
$1.33
derived: net income ÷ weighted average shares · filed 2026-08-03
2025-06-30$0.52
10-Q · filed 2026-08-03
$1.25
10-Q · filed 2026-08-03
$1.23
derived: net income ÷ weighted average shares · filed 2026-08-03
$2.11
derived: net income ÷ weighted average shares · filed 2026-08-03
2025-03-31$0.72
10-Q · filed 2026-05-08
$0.70
derived: net income ÷ weighted average shares · filed 2026-05-08
$1.58
derived: net income ÷ weighted average shares · filed 2026-05-08
$2.35
derived: net income ÷ weighted average shares · filed 2026-05-08
2024-12-31-$0.02
10-K · filed 2025-02-14
$0.86
derived: net income ÷ weighted average shares · filed 2026-02-20
$1.63
derived: net income ÷ weighted average shares · filed 2026-02-20
$2.40
10-K · filed 2026-02-20
2024-09-30$0.88
10-Q · filed 2025-11-04
$1.65
derived: net income ÷ weighted average shares · filed 2025-11-04
$2.41
10-Q · filed 2025-11-04
$2.87
derived: net income ÷ weighted average shares · filed 2026-02-20
2024-06-30$0.77
10-Q · filed 2025-08-04
$1.54
10-Q · filed 2025-08-04
$2.00
derived: net income ÷ weighted average shares · filed 2026-02-20
$3.00
derived: net income ÷ weighted average shares · filed 2026-02-20
2024-03-31$0.77
10-Q · filed 2025-05-09
$1.23
derived: net income ÷ weighted average shares · filed 2026-02-20
$2.23
derived: net income ÷ weighted average shares · filed 2026-02-20
$3.37
derived: net income ÷ weighted average shares · filed 2026-02-20
2023-12-31$0.46
10-K · filed 2024-02-20
$1.46
derived: net income ÷ weighted average shares · filed 2026-02-20
$2.60
derived: net income ÷ weighted average shares · filed 2026-02-20
$2.73
10-K · filed 2026-02-20
2023-09-30$1.00
10-Q · filed 2024-11-04
$2.14
derived: net income ÷ weighted average shares · filed 2024-11-04
$2.27
10-Q · filed 2024-11-04
$3.66
derived: net income ÷ weighted average shares · filed 2025-02-14
2023-06-30$1.14
10-Q · filed 2024-08-07
$1.27
10-Q · filed 2024-08-07
$2.66
derived: net income ÷ weighted average shares · filed 2025-02-14
$4.88
derived: net income ÷ weighted average shares · filed 2025-02-14
2023-03-31$0.13
10-Q · filed 2024-05-03
$1.52
derived: net income ÷ weighted average shares · filed 2025-02-14
$3.74
derived: net income ÷ weighted average shares · filed 2025-02-14
$4.26
derived: net income ÷ weighted average shares · filed 2025-02-14
2022-12-31$1.39
10-K · filed 2023-02-17
$3.61
derived: net income ÷ weighted average shares · filed 2025-02-14
$4.13
derived: net income ÷ weighted average shares · filed 2025-02-14
$6.65
10-K · filed 2025-02-14
2022-09-30$2.22
10-Q · filed 2023-11-06
$2.74
derived: net income ÷ weighted average shares · filed 2023-11-06
$5.26
10-Q · filed 2023-11-06
$7.53
derived: net income ÷ weighted average shares · filed 2024-02-20
2022-06-30$0.52
10-Q · filed 2023-08-07
$3.04
10-Q · filed 2023-08-07
$5.31
derived: net income ÷ weighted average shares · filed 2024-02-20
$7.09
derived: net income ÷ weighted average shares · filed 2024-02-20
2022-03-31$2.52
10-Q · filed 2023-05-05
$4.79
derived: net income ÷ weighted average shares · filed 2024-02-20
$6.58
derived: net income ÷ weighted average shares · filed 2024-02-20
$7.00
derived: net income ÷ weighted average shares · filed 2024-02-20
2021-12-31$2.27
10-K · filed 2022-02-18
$4.05
derived: net income ÷ weighted average shares · filed 2024-02-20
$4.48
derived: net income ÷ weighted average shares · filed 2024-02-20
$6.48
10-K · filed 2024-02-20
2021-09-30$1.78
10-Q · filed 2022-11-04
$2.21
derived: net income ÷ weighted average shares · filed 2022-11-04
$4.21
10-Q · filed 2022-11-04
$4.21
derived: net income ÷ weighted average shares · filed 2023-02-17
2021-06-30$0.42
10-Q · filed 2022-08-04
$2.42
10-Q · filed 2022-08-04
$2.43
derived: net income ÷ weighted average shares · filed 2023-02-17
$3.72
derived: net income ÷ weighted average shares · filed 2023-02-17
2021-03-31$2.00
10-Q · filed 2022-05-06
$2.01
derived: net income ÷ weighted average shares · filed 2023-02-17
$3.30
derived: net income ÷ weighted average shares · filed 2023-02-17
$2.92
derived: net income ÷ weighted average shares · filed 2023-02-17
2020-12-31$0.01
10-K · filed 2021-02-19
$1.31
derived: net income ÷ weighted average shares · filed 2023-02-17
$0.90
derived: net income ÷ weighted average shares · filed 2023-02-17
$2.73
10-K · filed 2023-02-17
2020-09-30$1.30
10-Q · filed 2021-11-02
$0.90
derived: net income ÷ weighted average shares · filed 2021-11-02
$2.78
10-Q · filed 2021-11-02
$4.59
derived: net income ÷ weighted average shares · filed 2022-02-18
2020-06-30-$0.46
10-Q · filed 2021-08-02
$1.44
10-Q · filed 2021-08-02
$3.27
derived: net income ÷ weighted average shares · filed 2022-02-18
$4.53
derived: net income ÷ weighted average shares · filed 2022-02-18
2020-03-31$2.02
10-Q · filed 2021-05-07
$3.90
derived: net income ÷ weighted average shares · filed 2022-02-18
$5.17
derived: net income ÷ weighted average shares · filed 2022-02-18
$5.66
derived: net income ÷ weighted average shares · filed 2022-02-18
2019-12-31$1.88
10-K · filed 2020-02-21
$3.14
derived: net income ÷ weighted average shares · filed 2022-02-18
$3.64
derived: net income ÷ weighted average shares · filed 2022-02-18
$5.30
10-K · filed 2022-02-18
2019-09-30$1.27
10-Q · filed 2020-11-04
$1.76
derived: net income ÷ weighted average shares · filed 2020-11-04
$3.41
10-Q · filed 2020-11-04
$2.18
derived: net income ÷ weighted average shares · filed 2021-02-19
2019-06-30$0.49
10-Q · filed 2020-08-04
$2.15
10-Q · filed 2020-08-04
$0.91
derived: net income ÷ weighted average shares · filed 2021-02-19
$2.74
derived: net income ÷ weighted average shares · filed 2021-02-19
2019-03-31$1.65
10-Q · filed 2020-05-08
$0.42
derived: net income ÷ weighted average shares · filed 2021-02-19
$2.24
derived: net income ÷ weighted average shares · filed 2021-02-19
$3.52
derived: net income ÷ weighted average shares · filed 2021-02-19
2018-12-31-$1.23
10-K · filed 2020-02-21
$0.61
derived: net income ÷ weighted average shares · filed 2021-02-19
$1.89
derived: net income ÷ weighted average shares · filed 2021-02-19
$3.67
10-K · filed 2021-02-19
2018-09-30$1.81
10-K · filed 2020-02-21
$3.06
derived: net income ÷ weighted average shares · filed 2019-11-06
$4.81
10-Q · filed 2019-11-06
$4.81
derived: net income ÷ weighted average shares · filed 2020-02-21
2018-06-30$1.26
10-K · filed 2020-02-21
$3.00
10-Q · filed 2019-08-05
$3.03
derived: net income ÷ weighted average shares · filed 2020-02-21
$4.04
derived: net income ÷ weighted average shares · filed 2020-02-21
2018-03-31$1.74
10-K · filed 2020-02-21
$1.77
derived: net income ÷ weighted average shares · filed 2020-02-21
$2.79
derived: net income ÷ weighted average shares · filed 2020-02-21
$3.98
derived: net income ÷ weighted average shares · filed 2020-02-21
2017-12-31$0.03
10-K · filed 2019-02-27
$1.05
derived: net income ÷ weighted average shares · filed 2020-02-21
$2.24
derived: net income ÷ weighted average shares · filed 2020-02-21
$3.31
10-K · filed 2020-02-21
2017-09-30$1.02
10-K · filed 2019-02-27
$2.21
derived: net income ÷ weighted average shares · filed 2018-11-07
$3.28
10-Q · filed 2018-11-07
$4.13
derived: net income ÷ weighted average shares · filed 2019-02-27
2017-06-30$1.20
10-K · filed 2019-02-27
$2.26
10-Q · filed 2018-08-07
$3.11
derived: net income ÷ weighted average shares · filed 2019-02-27
$4.09
derived: net income ÷ weighted average shares · filed 2019-02-27
2017-03-31$1.07
10-K · filed 2019-02-27
$1.92
derived: net income ÷ weighted average shares · filed 2019-02-27
$2.90
derived: net income ÷ weighted average shares · filed 2019-02-27
$3.88
derived: net income ÷ weighted average shares · filed 2019-02-27
2016-12-31$0.86
10-K · filed 2018-02-16
$1.83
derived: net income ÷ weighted average shares · filed 2019-02-27
$2.82
derived: net income ÷ weighted average shares · filed 2019-02-27
$3.65
10-K · filed 2019-02-27
2016-09-30$0.97
10-K · filed 2018-02-16
$1.96
derived: net income ÷ weighted average shares · filed 2017-11-07
$2.79
10-Q · filed 2017-11-07
$3.73
derived: net income ÷ weighted average shares · filed 2018-02-16
2016-06-30$0.99
10-K · filed 2018-02-16
$1.82
10-Q · filed 2017-08-07
$2.75
derived: net income ÷ weighted average shares · filed 2018-02-16
$3.49
derived: net income ÷ weighted average shares · filed 2018-02-16
2016-03-31$0.83
10-K · filed 2018-02-16
$1.76
derived: net income ÷ weighted average shares · filed 2018-02-16
$2.51
derived: net income ÷ weighted average shares · filed 2018-02-16
$3.35
derived: net income ÷ weighted average shares · filed 2018-02-16
2015-12-31$0.93
10-K · filed 2017-02-17
$1.67
derived: net income ÷ weighted average shares · filed 2018-02-16
$2.52
derived: net income ÷ weighted average shares · filed 2018-02-16
$3.15
10-K · filed 2018-02-16
2015-09-30$0.75
10-K · filed 2017-02-17
$1.59
derived: net income ÷ weighted average shares · filed 2016-11-07
$2.22
10-Q · filed 2016-11-07
$1.74
derived: net income ÷ weighted average shares · filed 2017-02-17
2015-06-30$0.84
10-K · filed 2017-02-17
$1.48
10-Q · filed 2016-08-05
$0.98
derived: net income ÷ weighted average shares · filed 2017-02-17
$1.30
derived: net income ÷ weighted average shares · filed 2017-02-17
2015-03-31$0.64
10-K · filed 2017-02-17
$0.13
derived: net income ÷ weighted average shares · filed 2017-02-17
$0.45
derived: net income ÷ weighted average shares · filed 2017-02-17
$1.14
derived: net income ÷ weighted average shares · filed 2017-02-17
2014-12-31-$0.51
10-K · filed 2016-02-19
-$0.19
derived: net income ÷ weighted average shares · filed 2017-02-17
$0.50
derived: net income ÷ weighted average shares · filed 2017-02-17
$1.11
10-K · filed 2017-02-17
2014-09-30$0.32
10-K · filed 2016-02-19
$1.01
derived: net income ÷ weighted average shares · filed 2016-02-19
$1.61
10-Q · filed 2015-11-06
$2.33
derived: net income ÷ weighted average shares · filed 2016-02-19
2014-06-30$0.69
10-K · filed 2016-02-19
$1.30
10-Q · filed 2015-08-07
$2.01
derived: net income ÷ weighted average shares · filed 2016-02-19
$2.62
derived: net income ÷ weighted average shares · filed 2016-02-19
2014-03-31$0.61
10-K · filed 2016-02-19
$1.32
derived: net income ÷ weighted average shares · filed 2016-02-19
$1.93
derived: net income ÷ weighted average shares · filed 2016-02-19
$2.60
derived: net income ÷ weighted average shares · filed 2016-02-19
2013-12-31$0.70
10-K · filed 2015-02-20
$1.31
derived: net income ÷ weighted average shares · filed 2016-02-19
$1.99
derived: net income ÷ weighted average shares · filed 2016-02-19
$2.58
10-K · filed 2016-02-19
2013-09-30$0.60
10-K · filed 2015-02-20
$1.28
derived: net income ÷ weighted average shares · filed 2015-02-20
$1.88
10-Q · filed 2014-11-07
$2.86
derived: net income ÷ weighted average shares · filed 2015-02-20
2013-06-30$0.67
10-K · filed 2015-02-20
$1.28
10-Q · filed 2014-08-07
$2.26
derived: net income ÷ weighted average shares · filed 2015-02-20
$3.26
derived: net income ÷ weighted average shares · filed 2015-02-20
2013-03-31$0.61
10-K · filed 2015-02-20
$1.58
derived: net income ÷ weighted average shares · filed 2015-02-20
$2.59
derived: net income ÷ weighted average shares · filed 2015-02-20
$3.39
derived: net income ÷ weighted average shares · filed 2015-02-20
2012-12-31$0.98
10-K · filed 2014-02-21
$1.98
derived: net income ÷ weighted average shares · filed 2015-02-20
$2.79
derived: net income ÷ weighted average shares · filed 2015-02-20
$3.35
10-K · filed 2015-02-20
2012-09-30$1.01
10-K · filed 2014-02-21
$1.81
derived: net income ÷ weighted average shares · filed 2014-02-21
$2.37
10-Q · filed 2013-11-12
2012-06-30$0.80
10-K · filed 2014-02-21
$1.36
10-Q · filed 2013-08-09
2012-03-31$0.56
10-K · filed 2014-02-21
2011-12-31$2.18
10-K · filed 2014-02-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
Merck & Co., Inc. (MRK)United States$365.215B99.96
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60